PAROSTEAL OSTEOSARCOMA - A CLINICOPATHOLOGICAL STUDY

被引:157
作者
OKADA, K
FRASSICA, FJ
SIM, FH
BEABOUT, JW
BOND, JR
UNNI, KK
机构
[1] MAYO CLIN & MAYO FDN,DEPT ORTHOPED,SURG PATHOL SECT,200 1ST ST SW,ROCHESTER,MN 55905
[2] MAYO CLIN & MAYO FDN,DEPT DIAGNOST RADIOL,ROCHESTER,MN 55905
关键词
D O I
10.2106/00004623-199403000-00007
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
The records of 226 patients (sixty-seven who were managed at our institution and 159 who were identified from the consultation riles) who had had a parosteal osteosarcoma were reviewed. The criteria for diagnosis were that, roentgenographically, the lesion had arisen from the surface of the bone and that, histologically, the tumor was well differentiated (Grade 1 or 2); it was characterized by well formed osteoid within a spindle-cell stroma; and, when there was medullary involvement, less than 25 per cent of the medullary cavity was affected. Dedifferentiation was more common (16 per cent of the patients) than previously reported and was associated with a poor prognosis. Cross-sectional imaging studies demonstrated medullary involvement in 22 per cent of the patients, an unmineralized soft-tissue mass peripheral to the mineral component in 51 per cent, and adjacent soft-tissue invasion in 46 per cent. In contrast to the findings in our previous studies, medullary involvement was not a poor prognostic factor. At an average of thirteen years (range, two to forty-one years), eleven of the sixty-seven patients who were managed at our institution died of the tumor; ten of these patients had a dedifferentiated tumor. Statistical analysis of the thirty-nine patients who had had the primary treatment at our institution revealed that incomplete resection was associated with an increased risk of local recurrence and that dedifferentiation markedly increased the risk of metastasis.
引用
收藏
页码:366 / 378
页数:13
相关论文
共 33 条
  • [1] JUXTACORTICAL (PAROSTEAL) OSTEOGENIC-SARCOMA - HISTOLOGICAL GRADING AND PROGNOSIS
    AHUJA, SC
    VILLACIN, AB
    SMITH, J
    BULLOUGH, PG
    HUVOS, AG
    MARCOVE, RC
    [J]. JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1977, 59 (05) : 632 - 647
  • [2] THE MEANING OF RADIOLUCENCIES IN PAROSTEAL OSTEO-SARCOMA
    BERTONI, F
    PRESENT, D
    HUDSON, T
    ENNEKING, WF
    [J]. JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1985, 67A (06) : 901 - 910
  • [3] PAROSTEAL OSTEO-SARCOMA
    CAMPANACCI, M
    PICCI, P
    GHERLINZONI, F
    GUERRA, A
    BERTONI, F
    NEFF, JR
    [J]. JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME, 1984, 66 (03): : 313 - 321
  • [4] DAHLIN DC, 1986, BONE TUMORS GENERAL, P269
  • [5] DUNHAM WK, 1979, CANCER, V44, P1495, DOI 10.1002/1097-0142(197910)44:4<1495::AID-CNCR2820440445>3.0.CO
  • [6] 2-J
  • [7] PAROSTEAL (JUXTACORTICAL) OSTEOGENIC SARCOMA
    DWINNELL, LA
    DAHLIN, DC
    GHORMLEY, RK
    [J]. JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1954, 36-A (04) : 732 - 744
  • [8] THE SURGICAL-TREATMENT OF PAROSTEAL OSTEO-SARCOMA IN LONG BONES
    ENNEKING, WF
    SPRINGFIELD, D
    GROSS, M
    [J]. JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1985, 67A (01) : 125 - 135
  • [9] PAROSTEAL OSTEOMA OF BONE - A NEW ENTITY
    GESCHICKTER, CF
    COPELAND, MM
    [J]. ANNALS OF SURGERY, 1951, 133 (06) : 790 - 807
  • [10] Huvos AG, 1991, BONE TUMORS DIAGNOSI, P157